Strs Ohio Buys 37,100 Shares of SPDR S&P Biotech ETF $XBI

Strs Ohio boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.8% during the 2nd quarter, HoldingsChannel reports. The fund owned 379,900 shares of the exchange traded fund’s stock after purchasing an additional 37,100 shares during the period. Strs Ohio’s holdings in SPDR S&P Biotech ETF were worth $31,505,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Investment Partners Asset Management Inc. increased its stake in SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after acquiring an additional 125 shares during the last quarter. Compass Ion Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.9% during the second quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock worth $309,000 after acquiring an additional 140 shares during the last quarter. McAdam LLC increased its stake in SPDR S&P Biotech ETF by 5.1% during the second quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 159 shares during the last quarter. First Heartland Consultants Inc. boosted its position in shares of SPDR S&P Biotech ETF by 2.7% during the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock valued at $514,000 after buying an additional 168 shares during the period. Finally, Calton & Associates Inc. boosted its position in shares of SPDR S&P Biotech ETF by 3.2% during the first quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock valued at $459,000 after buying an additional 175 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $111.91 on Friday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $113.21. The business has a 50 day simple moving average of $99.85 and a two-hundred day simple moving average of $88.92. The firm has a market capitalization of $6.82 billion, a PE ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.